Suchergebnisse - "Koehler, Philipp"

PubPharm (95)

1

SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir

enthalten in: The Journal of infectious diseases | 2024

von Singh, K. | Rubenstein, K. | Callier, V. | +125

2

Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU) : 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

enthalten in: Intensive care medicine | 2024

von Bassetti, M. | Giacobbe, D. | Agvald-Ohman, C. | +50

3

The Cologne ECMM Excellence Center : A Two-Year Analysis of External Consultation Service for Invasive Fungal Infections

enthalten in: Mycopathologia | 2024

von Salmanton-García, J. | Koehler, P. | Grothe, J. | +6

4

Analysis of acute COVID-19 including chronic morbidity : protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)

enthalten in: Infection | 2024

von Steinbeis, F. | Thibeault, C. | Steinbrecher, S. | +80

5

Questioning the 14-day dogma in candidemia treatment duration

enthalten in: Mycoses | 2024

von Salmanton-García, J. | Reinhold, I. | Prattes, J. | +3

6

Predicting the next pandemic : VACCELERATE ranking of the WorldHealth Organization's Blueprint forAction toPreventEpidemics

enthalten in: Travel medicine and infectious disease | 2024

von Salmanton-García, J. | Wipfler, P. | Leckler, J. | +110

7

Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection : an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort

enthalten in: Infection | 2023

von Shi, Y. | Strobl, R. | Apfelbacher, C. | +121

8

Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia : Results from the ECMM Candida III Multinational European Observational Cohort Study

enthalten in: Mycopathologia | 2023

von Egger, M. | Salmanton-García, J. | Barac, A. | +51

9

Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273 : A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)

enthalten in: Vaccine | 2023

von Neuhann, J. | Stemler, J. | Carcas, A. | +25

10

European candidaemia is characterised by notable differential epidemiology and susceptibility pattern : Results from the ECMM Candida III study

enthalten in: The Journal of infection | 2023

von Arendrup, M. | Arikan-Akdagli, S. | Jørgensen, K. | +44

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]